COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences Inc. Completes its Purchase of Crypto Currency Groestlcoin
19/01/2018
NEW YORK, NY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
PHM Announces Further Details of Plan of Arrangement
19/01/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
19/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
19/01/2018
AUSTIN, Texas, Jan. 19, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today that results from an open label extension (OLE) phase of the randomized Phase 2 study evaluating XBiotech’s True Human™ [...]
Albireo to Receive More than $55 Million(1) in Nondilutive Cash Payments
19/01/2018
— Elobixibat approved in Japan for the treatment of chronic constipation — — Albireo innovation leads to world’s first approved ileal bile acid transporter (IBAT) inhibitor — BOSTON, Jan. 19, 2018 (GLOBE NEWSWIRE) -- [...]
Avinger Granted Continued Listing Decision From Nasdaq
19/01/2018
REDWOOD CITY, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the Company has received [...]
VitalHub Corp. Announces the Acquisition of Clarity Healthcare Solutions
19/01/2018
TORONTO, Jan. 19, 2018 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV:VHI) (the “Company” or “VitalHub”), is pleased to announce that it has acquired Clarity Healthcare Solutions and other selected assets of Clarity Health [...]
Kraig Biocraft Laboratories Creates First Hybrids in New Research Center
19/01/2018
ANN ARBOR, Mich., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company succeeded in creating a [...]
Saniona AB: Bulletin from the extraordinary shareholders' meeting on January 19, 2018 in Saniona AB
19/01/2018
PRESS RELEASE January 19, 2018 Today, on January 19, 2018, an extraordinary shareholders' meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted with the [...]
Shire plc : Directorate change
19/01/2018
Directorate Change Dublin, Ireland - January 19, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Thomas Dittrich will assume his role as Chief Financial Officer, and become an Executive member [...]
Zealand Pharma strengthens its Management by appointing Ivan Møller as SVP, Technical Development & Operations
19/01/2018
Company announcement - No. 3/2018 Zealand Pharma strengthens its Management by appointing Ivan Møller as SVP, Technical Development & Operations Copenhagen, Denmark, January 19, 2018 - Zealand Pharma A/S ("Zealand [...]
Arimoclomol for NPC receives Rare Pediatric Disease Designation
19/01/2018
Company announcement Orphazyme A/S No. 01/2018 Copenhagen, Denmark, January 19, 2018 – Orphazyme A/S, a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, [...]
Motif Bio Announces Filing of U.S. Shelf Registration
19/01/2018
NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Motif Bio® plc (AIM/NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has filed a “ [...]
Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis
19/01/2018
Brachyury plays a key role in metastasis and progression of tumors and is overexpressed in several major, as well as orphan cancers COPENHAGEN, Denmark, January 19, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) [...]
Santhera Plans to Announce Regulatory Feedback for Raxone® in DMD and 2017 Preliminary Key Financial Figures
19/01/2018
Liestal, Switzerland, January 19, 2018 - Santhera Pharmaceuticals (SIX: SANN) expects to announce feedback from the CHMP on its Marketing Authorization Application (MAA) for Raxone® in Duchenne muscular dystrophy (DMD) [...]
Obalon Therapeutics Prices Public Offering of Common Stock
19/01/2018
SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Agios Announces Pricing of $475 Million Public Offering of Common Stock
19/01/2018
CAMBRIDGE, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ) today announced that it has priced an underwritten public offering of 7,089,553 shares of common stock at a price to the [...]
HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock
19/01/2018
TUCSON, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the pricing [...]
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
19/01/2018
RA'ANANA, Israel and NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Pages